BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2446559)

  • 21. Myasthenia gravis: how to treat?
    Tireli H; Karlikaya G; Tutkavul K; Akpinar A; Okay T
    Acta Myol; 2004 Dec; 23(3):140-5. PubMed ID: 15938570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrence of nonneoplastic thymus after thymectomy for myasthenia gravis. Report of two cases.
    Joseph BS; Johns TR
    Neurology; 1973 Feb; 23(2):109-16. PubMed ID: 4347062
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapeutic considerations in myasthenia gravis].
    Vejvalka J
    Cesk Neurol Neurochir; 1984 Mar; 47(2):78-84. PubMed ID: 6705094
    [No Abstract]   [Full Text] [Related]  

  • 24. Therapeutic options in autoimmune myasthenia gravis.
    García-Carrasco M; Escárcega RO; Fuentes-Alexandro S; Riebeling C; Cervera R
    Autoimmun Rev; 2007 Jun; 6(6):373-8. PubMed ID: 17537383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myasthenia gravis during pregnancy.
    Chaudhry SA; Vignarajah B; Koren G
    Can Fam Physician; 2012 Dec; 58(12):1346-9. PubMed ID: 23242891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of therapeutic plasmapheresis in patients with generalized myasthenia during exacerbations in the late period following thymectomy].
    Marchuk AI; Golovteev VV; Sapin SM; Shagal DI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(3):330-3. PubMed ID: 3705836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the results of different therapeutic measures in 198 myasthenia gravis patients.
    Apostolski S; Lavrnić D; Djukić P; Trikić R; Gospavić J; Dotlić R; Pavlović S
    Monogr Allergy; 1988; 25():86-95. PubMed ID: 3173364
    [No Abstract]   [Full Text] [Related]  

  • 28. Management of myasthenia gravis.
    Lancet; 1972 Apr; 1(7754):780-1. PubMed ID: 4111252
    [No Abstract]   [Full Text] [Related]  

  • 29. Myasthenia gravis and pregnancy.
    Burke ME
    J Perinat Neonatal Nurs; 1993 Jun; 7(1):11-21. PubMed ID: 8336287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overview of myasthenia gravis.
    Arora Y; Li Y
    Hosp Pract (1995); 2013; 41(4):40-50. PubMed ID: 24145588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of plasmapheresis in combined treatment of patients with severe form of generalized myasthenia].
    Zaĭtsev VT; Krivoruchko IA; Klimova EM; Bondarenko TN; Florikian AK; Nechitaĭlo PE; Zhurov IuE; Shaposhnikov GA; Asanbaev AF
    Klin Khir (1962); 1994; (4):33-5. PubMed ID: 7799584
    [No Abstract]   [Full Text] [Related]  

  • 32. Corticotropin therapy and thymectomy in management of severe, generalized myasthenia gravis.
    Namba T; Shapiro MS; Brunner NG; Grob D
    Trans Am Neurol Assoc; 1970; 95():295-7. PubMed ID: 4328100
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunological and therapeutic aspects of myasthenia gravis (author's transl)].
    Ghezzi M; Taiuti R; Marconi G
    Riv Patol Nerv Ment; 1981; 102(1):12-28. PubMed ID: 6285444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Myasthenia gravis--an autoimmune neuromuscular disease].
    Pirskanen-Matell R; Matell G; Kalb B; Bjelak S
    Lakartidningen; 2000 Oct; 97(41):4594-8. PubMed ID: 11107745
    [No Abstract]   [Full Text] [Related]  

  • 35. [Myasthenia gravis. Immunosuppressive treatment].
    Horn J
    Tidsskr Nor Laegeforen; 1971 Apr; 91(11):821-4. PubMed ID: 4326179
    [No Abstract]   [Full Text] [Related]  

  • 36. Thymectomy as primary therapy in myasthenia gravis.
    Olanow CW; Wechsler AS; Sirotkin-Roses M; Stajich J; Roses AD
    Ann N Y Acad Sci; 1987; 505():595-606. PubMed ID: 3479941
    [No Abstract]   [Full Text] [Related]  

  • 37. Biology of myasthenia gravis.
    Lindstrom J; Dau P
    Annu Rev Pharmacol Toxicol; 1980; 20():337-62. PubMed ID: 6992700
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of plasmapheresis in myasthenia gravis.
    Perlo VP; Shahani BT; Huggins CE; Hunt J; Kosinski K; Potts F
    Ann N Y Acad Sci; 1981; 377():709-24. PubMed ID: 6951495
    [No Abstract]   [Full Text] [Related]  

  • 39. The importance of the time interval between diagnosis and operation in myasthenia gravis patients.
    Dural K; Yildirim E; Han S; Ozişik K; Ulaşan N; Saygin H; Sakinci U
    J Cardiovasc Surg (Torino); 2003 Feb; 44(1):125-9. PubMed ID: 12627084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Scientific overview of myasthenia gravis and an assessment of the role of plasmapheresis.
    Tindall RS
    Prog Clin Biol Res; 1982; 106():113-42. PubMed ID: 6757936
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.